Navigation Links
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
Date:4/11/2011

ing untested biotech products departs dramatically from Cephalon's historical focus of marketing products other companies have primarily developed and taken through the regulatory process.
  • Cephalon is not a high-growth biotechnology company.  Provigil, which accounted for approximately 41% of its net sales in fiscal year 2010, will face generic competition next year.  Based on IBES consensus equity research estimates, from 2011-2013, Cephalon's revenues and EPS are expected to fall by 20% and 42%, respectively.
  • Cephalon's share price performance prior to Valeant's offer reflected its declining fundamental value. Repeated pipeline failures and an inability to fill the impending loss of Provigil have negatively impacted Cephalon's valuation.  In fact, Cephalon's 52-week high was following rumors of a sale process and dropped off sharply after Cephalon was unable to attain approval for Nuvigil for the treatment of jet lag.  Concern over Cephalon's business model was demonstrated by 68% of Wall Street analysts having ratings equivalent to "sell" or "hold" prior to Valeant's offer.
  • Valeant's offer represents a full and fair premium. Valeant's $73 per share all cash offer represents a 29% premium to Cephalon's 30-day trading average at announcement.  The median premium to 30-day trading averages in all U.S. acquisitions since 2006 was 25%, and 60% of those acquisitions were completed at a premium of less than 30% to 30-day trading averages.  In addition, Valeant's offer already accounts for the substantial value leakage due to change of control costs for Cephalon's convertible debt and call spread.

    • Timing is critical to Valeant.  Wall Street analysts project Cephalon's earnings to decline by more than 40% after Provigil loses patent protection in 2012.  Cephalon's value to Valeant erodes each day Valeant is delayed in implementing its business strategy as Provi
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
    2. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
    3. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
    4. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
    5. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
    6. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
    7. Valeant Announces Pricing of Senior Notes
    8. Valeant Launches Senior Notes Offering
    9. Valeant Pharmaceuticals to Present at RBC Capital Markets 2011 Healthcare Conference
    10. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
    11. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
    (Date:5/24/2013)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), ... China , announced that Sinovac Beijing, ... the Certificate of Good Manufacturing Practices for Pharmaceutical ... Food Administration (CFDA) for its proprietary vaccines, its ... filing and packaging facility. The GMP certificate covers ...
    (Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
    Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
    ... College of Surgeons (ACS) today announced its goal to ... Surgical Quality Improvement Program (ACS NSQIP®). The commitment is ... launched today, an effort to raise awareness of proven ... that can help improve the quality and value of ...
    ... voluntary nationwide recall to the user and consumer level of the following ... Pharmacy Bulk Package, Lot # 1006, Expiration Date: January 2013, ... PL EASE NOTE:  This voluntary nationwide recall, initiated on ... # 1006 only. No other sizes or lots of Calcium Gluconate Injection, ...
    Cached Medicine Technology:American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 2American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 3American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 4American College of Surgeons Announces Goal to Enlist 1,000 Hospitals to its National Surgical Quality Improvement Program 5American Regent Initiates Voluntary Nationwide Recall of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package Due to Particulates 2American Regent Initiates Voluntary Nationwide Recall of Calcium Gluconate Injection, USP, 10%, 100 mL Pharmacy Bulk Package Due to Particulates 3
    (Date:5/25/2013)... Springs, FL (PRWEB) May 25, 2013 ... Dallas-Ft. Worth, Texas. It is the fifth largest media market ... Dallas is the number one visitor destination in Texas and ... cultural gateway to the American West as it is home ... activities everyone will enjoy from sports to the arts. Residents ...
    (Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...
    (Date:5/25/2013)... 25, 2013 Radius Engineering International ... company in the US and has been building ... over 35 years. M.E. and President, Walton McCarthy, ... NBC Weapon Fundamentals and Shelter Engineering Standards, Sixth ... on shelter engineering. McCarthy is considered the leading ...
    (Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center ... businesses throughout the country participating in Shop Local for a ... nationwide event as he understands what military families go through ... He said, “I wanted to give something back, as I ... live here too.” , Shop Local for a Cause has ...
    (Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...
    Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
    ... drug called Ocrelizumab has shown promise in a Phase ... (MS), an often debilitating, chronic autoimmune disease that affects ... usually strikes young adults and is more common in ... by researchers at the University of California, San Francisco ...
    ... , TUESDAY, Nov. 1 (HealthDay News) -- Organ transplant recipients ... compared to the general population. And that risk is elevated ... In any given year, however, the risk ... And experts say the benefits of transplantation far outweigh such ...
    ... Arizona State University (ASU) and California State University, Long ... experts trained in the skills and equipped with the ... quality of their lives. In early 2012 the ... fellowships to pursue studies and work experience in multiple ...
    ... year on dieting advice and self-help books, but the first step ... the plate. If keeping a food diary seems like too ... Engineering and Applied Sciences (SEAS) have devised a tool that lets ... do the rest. PlateMate,s calorie estimates have proved, in tests, ...
    ... HealthDay Reporter , TUESDAY, Nov. 1 (HealthDay News) -- ... in a decade, hitting a peak of 36,000 fatalities in ... shocking news is that we are in the midst of ... R. Frieden, director of the U.S. Centers for Disease Control ...
    ... a genetic mutation which can cause sudden cardiac death. The ... life can be maintained with the right advice and support, ... University of Gothenburg, Sweden. The most common cause ... heart muscle disease hypertrophic cardiomyopathy. The condition is hereditary, and ...
    Cached Medicine News:Health News:New drug shows promise against multiple sclerosis 2Health News:New drug shows promise against multiple sclerosis 3Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 2Health News:Cancer Risk Doubles After Organ Transplant, Study Finds 3Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 2Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 3Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 4Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 5Health News:NSF-funded research fellowship program to focus on producing experts to aid people with disabilities 6Health News:Crowdsourcing nutrition in a snap 2Health News:Crowdsourcing nutrition in a snap 3Health News:Crowdsourcing nutrition in a snap 4Health News:Deaths From Abuse of Painkillers Triple in a Decade: CDC 2Health News:Deaths From Abuse of Painkillers Triple in a Decade: CDC 3Health News:Research supports broader screening for sudden cardiac death 2
    Angled 45 degree shafts. 7 mm from tip to bend with grooved 2 mm platform for grasping lens haptic. Serrated McPherson style handle with dull finish....
    Folding forceps used for L161U. Manufactured in titanium....
    ... Curvilinear design and reduced ... Offers excellent control of IOL ... periphery of the optic. Curved ... tips gently curved. Smooth, flat, ...
    ... Facilitates grasping and implanting the haptic ... within the capsular bag without wrist ... long jaws are placed in the ... Smooth, flat, cross action handle with ...
    Medicine Products: